AGN now investigating CKD treatment For everyone interested in biotech or pharma companies, Algernon Pharmaceuticals (AGN.c AGNPF) is a clinical-stage drug development and repurposing company that is currently investigating treatments for IPF, chronic cough, stroke, and TBI.
AGN also recently received a Notice of Allowance from the US Patent and Trademark Office for its patent application for its chronic kidney disease drug, Repirinast.
More info here: https://www.algernonpharmaceuticals.com/news-media/news-releases/detail/181/algernon-pharmaceuticals-announces-notice-of-allowance-for